Arcus Biosciences

Arcus Biosciences

Arcus Biosciences

Arcus Biosciences is a biotech company that visions to create new cancer therapeutics through the use of emerging insights in immunology.
Founded
2015
Raised
$177M
Follow us
Alexa global traffic share
Latest funding
$70,000,000
Venture capital (Series B) - 2016
Celgene Foresite Capital Invus +6
Team Size
10+
Employees
the home of AI info

Minerva Neurosciences Inc. (NERV)'s Financial Results Comparing With Arcus Biosciences Inc ...

Xconomy

Arcus Bio Pulls Off IPO, Raises $120M for Cancer Immunotherapies

Health
CrunchBase

Arcus Biosciences Raises $107 Million To Fight Cancer With Immunology News

Funding Health
$70,000,000 Venture capital (Series B)
FinSMEs

Arcus Biosciences Raises $70M in Series B Funding

Funding